References:
- Stenzel DJ, Boreham PF. Blastocystis hominis revisited. Clin Microbiol
Rev. 1996 Oct;9(4):563-84. doi: 10.1128/CMR.9.4.563. PMID: 8894352;
PMCID: PMC172910.
- CDC - dpdx - blastocystis hominis. Centers for Disease Control and
Prevention. October 21, 2019. Accessed June 24,
2024. https://www.cdc.gov/dpdx/blastocystis/index.html.
- Ustün S, Turgay N. Blastocystis hominis ve bağirsak hastaliklari
[Blastocystis hominis and bowel diseases]. Turkiye Parazitol Derg.
2006;30(1):72-6. Turkish. PMID: 17106862.
- Mayneris-Perxachs, J., Arnoriaga-Rodríguez, M., Garre-Olmo, J., Puig,
J., Ramos, R., Trelis, M., Burokas, A., Coll, C., Zapata-Tona, C.,
Pedraza, S., Pérez-Brocal, V., Ramió, L., Ricart, W., Moya, A., Jové,
M., Sol, J., Portero-Otin, M., Pamplona, R., Maldonado, R., &
Fernández-Real, J. M. (2022). Presence of Blastocystis in gut
microbiota is associated with cognitive traits and decreased executive
function. The ISME journal , 16 (9), 2181–2197.
https://doi.org/10.1038/s41396-022-01262-3’
- Tan K. S. (2008). New insights on classification, identification, and
clinical relevance of Blastocystis spp. Clinical microbiology
reviews , 21 (4), 639–665. https://doi.org/10.1128/CMR.00022-08
- Sender, R., Fuchs, S., & Milo, R. (2016). Revised Estimates for the
Number of Human and Bacteria Cells in the Body. PLoS
biology , 14 (8), e1002533.
https://doi.org/10.1371/journal.pbio.1002533
- Nishiwaki, H., Ito, M., Ishida, T., Hamaguchi, T., Maeda, T.,
Kashihara, K., Tsuboi, Y., Ueyama, J., Shimamura, T., Mori, H.,
Kurokawa, K., Katsuno, M., Hirayama, M., & Ohno, K. (2020).
Meta-Analysis of Gut Dysbiosis in Parkinson’s Disease. Movement
disorders : official journal of the Movement Disorder
Society , 35 (9), 1626–1635.
https://doi.org/10.1002/mds.28119
- Chaoul, V., Dib, E. Y., Bedran, J., Khoury, C., Shmoury, O., Harb, F.,
& Soueid, J. (2023). Assessing Drug Administration Techniques in
Zebrafish Models of Neurological Disease. International journal
of molecular sciences , 24 (19), 14898.
https://doi.org/10.3390/ijms241914898
- Berthouzoz, E., Lazarevic, V., Zekeridou, A., Castro, M., Debove, I.,
Aybek, S., Schrenzel, J., Burkhard, P. R., & Fleury, V. (2023). Oral
and intestinal dysbiosis in Parkinson’s disease. Revue
neurologique , 179 (9), 937–946.
https://doi.org/10.1016/j.neurol.2022.12.010
- Scanlan, P. D., Stensvold, C. R., Rajilić-Stojanović, M., Heilig, H.
G., De Vos, W. M., O’Toole, P. W., & Cotter, P. D. (2014). The
microbial eukaryote Blastocystis is a prevalent and diverse member of
the healthy human gut microbiota. FEMS microbiology
ecology , 90 (1), 326–330.
https://doi.org/10.1111/1574-6941.12396
- Beghini, F., Pasolli, E., Truong, T. D., Putignani, L., Cacciò, S. M.,
& Segata, N. (2017). Large-scale comparative metagenomics of
Blastocystis, a common member of the human gut microbiome. The
ISME journal , 11 (12), 2848–2863.
https://doi.org/10.1038/ismej.2017.139
- Nourrisson, C., Scanzi, J., Pereira, B., NkoudMongo, C., Wawrzyniak,
I., Cian, A., Viscogliosi, E., Livrelli, V., Delbac, F., Dapoigny, M.,
& Poirier, P. (2014). Blastocystis is associated with decrease of
fecal microbiota protective bacteria: comparative analysis between
patients with irritable bowel syndrome and control
subjects. PloS one , 9 (11), e111868.
https://doi.org/10.1371/journal.pone.0111868
- Yason, J. A., Liang, Y. R., Png, C. W., Zhang, Y., & Tan, K. S. W.
(2019). Interactions between a pathogenic Blastocystis subtype and gut
microbiota: in vitro and in vivo
studies. Microbiome , 7 (1), 30.
https://doi.org/10.1186/s40168-019-0644-3